Extracorporeal Membrane Oxygenation System Market - 2023-2031
The Extracorporeal Membrane Oxygenation System Market was valued at US$ 538.93 million in 2023 and is anticipated to reach US$ 708.44 million by 2031, at a CAGR of 0.0326 from 2026 to 2032.
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Extracorporeal Membrane Oxygenation System Market.
This report delivers a comprehensive overview of the Extracorporeal Membrane Oxygenation System Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Extracorporeal Membrane Oxygenation System Market. The Extracorporeal Membrane Oxygenation System Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2023–2031.
Extracorporeal Membrane Oxygenation System Market Scope:
By Modality Type
This report delivers a comprehensive overview of the Extracorporeal Membrane Oxygenation System Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Extracorporeal Membrane Oxygenation System Market. The Extracorporeal Membrane Oxygenation System Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2023–2031.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Extracorporeal Membrane Oxygenation System Market.
This report delivers a comprehensive overview of the Extracorporeal Membrane Oxygenation System Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Extracorporeal Membrane Oxygenation System Market. The Extracorporeal Membrane Oxygenation System Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2023–2031.
Extracorporeal Membrane Oxygenation System Market Scope:
By Modality Type
- Veno-venous (VV)
- Veno-arterial (VA)
- Arterio-venous (AV)
- ECMO Machines
- Software
- Pump
- Oxygenator
- Controller
- Cannula
- Accessories
- Neonatal
- Pediatrics
- Adult
- Respiratory
- Cardiac
- Extracorporeal Cardiopulmonary Resuscitation (ECPR)
- Medtronic plc.
- MAQUET Holding B. V. & Co. KG
- LivaNova PLC
- XENIOS AG
- Terumo Corporation
- MicroPort Scientific Corporation
- NIPRO Corporation
- OriGen Biomedical Inc
- Fresenius Medical care AG & Co. KGaA
- Getinge Group(LIST NOT EXHAUSTIVE)
This report delivers a comprehensive overview of the Extracorporeal Membrane Oxygenation System Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Extracorporeal Membrane Oxygenation System Market. The Extracorporeal Membrane Oxygenation System Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2023–2031.
This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Regional Analysis:
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
- Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
- South America (Colombia, Brazil, Argentina, Rest of South America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
- Increase Your Customer Base by 3X using our Partner Identification tool
- Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
- Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
- Prioritize partners by strategic fit rather than general capability.
- Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
- Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
- White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
- Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
- Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
- Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
1. METHODOLOGY AND SCOPE
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. MARKET DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. The increasing technological advancements
4.1.1.2. Rising novel product launches
4.1.2. Restraints:
4.1.2.1. High cost associated with extracorporeal membrane oxygenation system
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
6. COVID-19 ANALYSIS
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. BY MODALITY TYPE
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality Type
7.1.2. Market Attractiveness Index, By Modality Type
7.2. Veno-venous (VV) *
7.2.1. Introduction
7.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Veno-arterial (VA)
7.4. Arterio-venous (AV)
8. BY TYPE
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
8.1.2. Market Attractiveness Index, By Type
8.2. ECMO Machines *
8.2.1. Introduction
8.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Software
9. BY COMPONENT
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
9.1.2. Market Attractiveness Index, By Component
9.2. Pump *
9.2.1. Introduction
9.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. Oxygenator
9.4. Controller
9.5. Cannula
9.6. Accessories
10. BY AGE GROUP
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
10.1.2. Market Attractiveness Index, By Age Group
10.2. Neonatal *
10.2.1. Introduction
10.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
10.3. Pediatrics
10.4. Adult
11. BY APPLICATION
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.1.2. Market Attractiveness Index, By Application
11.2. Respiratory *
11.2.1. Introduction
11.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
11.3. Cardiac
11.4. Extracorporeal Cardiopulmonary Resuscitation (ECPR)
12. BY REGION
12.1. Introduction
12.1.1. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality Type
12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.2.7.1. U.S.
12.2.7.2. Canada
12.2.7.3. Mexico
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality Type
12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.3.8.1. Germany
12.3.8.2. U.K.
12.3.8.3. France
12.3.8.4. Italy
12.3.8.5. Spain
12.3.8.6. Rest of Europe
12.4. South America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality Type
12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.4.8.1. Brazil
12.4.8.2. Argentina
12.4.8.3. Rest of South America
12.5. Asia Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality Type
12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.5.8.1. China
12.5.8.2. India
12.5.8.3. Japan
12.5.8.4. Australia
12.5.8.5. Rest of Asia Pacific
12.6. Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality Type
12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13. COMPETITIVE LANDSCAPE
13.1. Key Developments and Strategies
13.2. Company Share Analysis
13.3. Products Benchmarking
13.4. List of Key Companies to Watch
14. COMPANY PROFILES
14.1. Medtronic plc.
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Key Highlights
14.1.4. Financial Overview
14.2. MAQUET Holding B. V. & Co. KG
14.3. LivaNova PLC
14.4. XENIOS AG
14.5. Terumo Corporation
14.6. MicroPort Scientific Corporation
14.7. NIPRO Corporation
14.8. OriGen Biomedical Inc
14.9. Fresenius Medical care AG & Co. KGaA
14.10. Getinge Group(*LIST NOT EXHAUSTIVE)
15. DATAM INTELLIGENCE
15.1. Appendix
15.2. About Us and Component
15.3. Contact Us
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. MARKET DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. The increasing technological advancements
4.1.1.2. Rising novel product launches
4.1.2. Restraints:
4.1.2.1. High cost associated with extracorporeal membrane oxygenation system
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
6. COVID-19 ANALYSIS
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. BY MODALITY TYPE
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality Type
7.1.2. Market Attractiveness Index, By Modality Type
7.2. Veno-venous (VV) *
7.2.1. Introduction
7.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Veno-arterial (VA)
7.4. Arterio-venous (AV)
8. BY TYPE
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
8.1.2. Market Attractiveness Index, By Type
8.2. ECMO Machines *
8.2.1. Introduction
8.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Software
9. BY COMPONENT
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
9.1.2. Market Attractiveness Index, By Component
9.2. Pump *
9.2.1. Introduction
9.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. Oxygenator
9.4. Controller
9.5. Cannula
9.6. Accessories
10. BY AGE GROUP
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
10.1.2. Market Attractiveness Index, By Age Group
10.2. Neonatal *
10.2.1. Introduction
10.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
10.3. Pediatrics
10.4. Adult
11. BY APPLICATION
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.1.2. Market Attractiveness Index, By Application
11.2. Respiratory *
11.2.1. Introduction
11.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
11.3. Cardiac
11.4. Extracorporeal Cardiopulmonary Resuscitation (ECPR)
12. BY REGION
12.1. Introduction
12.1.1. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality Type
12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.2.7.1. U.S.
12.2.7.2. Canada
12.2.7.3. Mexico
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality Type
12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.3.8.1. Germany
12.3.8.2. U.K.
12.3.8.3. France
12.3.8.4. Italy
12.3.8.5. Spain
12.3.8.6. Rest of Europe
12.4. South America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality Type
12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.4.8.1. Brazil
12.4.8.2. Argentina
12.4.8.3. Rest of South America
12.5. Asia Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality Type
12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.5.8.1. China
12.5.8.2. India
12.5.8.3. Japan
12.5.8.4. Australia
12.5.8.5. Rest of Asia Pacific
12.6. Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality Type
12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13. COMPETITIVE LANDSCAPE
13.1. Key Developments and Strategies
13.2. Company Share Analysis
13.3. Products Benchmarking
13.4. List of Key Companies to Watch
14. COMPANY PROFILES
14.1. Medtronic plc.
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Key Highlights
14.1.4. Financial Overview
14.2. MAQUET Holding B. V. & Co. KG
14.3. LivaNova PLC
14.4. XENIOS AG
14.5. Terumo Corporation
14.6. MicroPort Scientific Corporation
14.7. NIPRO Corporation
14.8. OriGen Biomedical Inc
14.9. Fresenius Medical care AG & Co. KGaA
14.10. Getinge Group(*LIST NOT EXHAUSTIVE)
15. DATAM INTELLIGENCE
15.1. Appendix
15.2. About Us and Component
15.3. Contact Us
